Skip to main content

UBS Group AG

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 1610520 ZURICH, V8

Position in RGC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$263,135
-$344,260 QoQ
Shares Held
43,208
+80.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 35 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RGC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. RGC ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGC

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $263,135 43,208
2026-03-31 $607,395 23,885
2025-12-31 $382,263 18,203
2025-09-30 $5,870 380
2025-06-30 $639,460 37,527
2024-12-31 $144,336 29,218
2024-09-30 $99,108 17,876
2024-06-30 $1,048 312
2024-03-31 $6,298 1,400
2023-12-31 $168,546 16,053
2023-03-31 $25 1
2022-12-31 $18,657 669
2022-09-30 $17,425 548
2022-06-30 $25,020 723
2022-03-31 $5,221 244
2021-12-31 $6,115 192